Collateral for a security interest recorded Apr 30, 2024 (Orbimed Royalty & Credit Opportunities IV, LP).
Term ends Mar 21, 2031 · High confidence
20-year base term ends Jul 2, 2030
Held by Trisalus Life Sciences, Inc.
Filed Nov 29, 2011 as application 13/306,105 · Granted Jan 10, 2017
Base term plus 1443 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2010
2031
Clock starts
Jul 2, 2010
Jul 2, 2010
Term ends
Mar 21, 2031
Mar 21, 2031
Granted
Jan 10, 2017
Jan 10, 2017
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,443
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,696,698, US 8,696,699, US 9,295,540, US 9,808,332.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1443 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 2, 2010, when application 12/829,565, the earliest non-provisional in its chain, was filed (this one was filed Nov 29, 2011) | Jul 2, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1443 days, USPTO patent term adjustment record | Jun 14, 2034 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,696,698, US 8,696,699, US 9,295,540, US 9,808,332) | capped to Mar 21, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 21, 2031 | High confidence |
This family
| US 8,500,775 | In force no later than Jul 2031 | no later than Jul 2031 |
| US 8,696,698 | In force Jun 2031 | Jun 2031 |
| US 8,696,699 | In force Jun 2031 | Jun 2031 |
| US 9,539,081 | this patent Mar 2031 | Mar 2031 |
| US 9,295,540 | In force Mar 2031 | Mar 2031 |
| US 9,808,332 | In force Mar 2031 | Mar 2031 |
| US 10,813,739 | In force Mar 2031 | Mar 2031 |
| US 12,201,508 | In force Jan 2033 | Jan 2033 |
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 22, 2012 Reel 28245, frame 241 | Chomas, James E.; Pinchuk, Leonard; Martin, John; Arepally, Aravind; Naglreiter, Brett E.; Weldon, Norman R.; Pinchuk, Bryan M. | Surefire Medical, Inc. | Assignment of Assignor's Interest |
| Sep 30, 2021 Reel 57693, frame 506 | Surefire Medical, Inc. | Trisalus Life Sciences, Inc. | Change of Name |
| Apr 30, 2024 Reel 67274, frame 733 | Trisalus Life Sciences, Inc. | Orbimed Royalty & Credit Opportunities IV, LP | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2031
Term ends Mar 21, 2031. Maintenance fees still fall due before then
Note
The 1443 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,696,698, US 8,696,699, US 9,295,540, US 9,808,332.
Citations
158
later US patents cite this one
That is top 5% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.